Clinical Neuropsychology: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Clin Neuropsycho 2023, Vol 6(2): 168
  • DOI: 10.4172/cnoa.1000168

Poor Treatment and the Probability of Patients Developing First-Stage Psychosis: a Study

Matteo Pacini*
Department of Psychiatry, Pisa University, Italy
*Corresponding Author : Matteo Pacini, Department of Psychiatry, Pisa University, Italy, Email: Matteo.p@gmail.com

Received Date: Mar 30, 2023 / Accepted Date: Apr 22, 2023 / Published Date: Apr 27, 2023

Abstract

Pot utilize following the beginning of first-episode psychosis has been connected to both expanded hazard of backslide and non-adherence with antipsychotic prescription. It is unclear whether cannabis's negative effect on medication adherence mediated the poor outcomes associated with cannabis use. The negative effects of cannabis use in psychosis may be partially mitigated by medication adherence interventions.

Citation: Pacini M (2023) Poor treatment and the probability of patients developing first-stage Psychosis: A study. Clin Neuropsycho, 6: 168. Doi: 10.4172/cnoa.1000168

Copyright: © 2023 Pacini M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top